Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy

Altered number, subset composition, and function of bone marrow innate lymphoid cells are early events in monoclonal gammopathies. Pomalidomide therapy leads to reduction in Ikzf1 and Ikzf3 and enhanced human innate lymphoid cell function in vivo.

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Kini Bailur, Jithendra, Mehta, Sameet, Zhang, Lin, Neparidze, Natalia, Parker, Terri, Bar, Noffar, Anderson, Tara, Xu, Mina L., Dhodapkar, Kavita M., Dhodapkar, Madhav V.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Stimulus Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729633/
https://ncbi.nlm.nih.gov/pubmed/29296884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017012732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados